Komori
Changes in Officers4886ASKA Pharmaceutical Holdings Co.,Ltd.Pharmaceuticals

Notice Concerning Organizational Changes, Changes in Executive Officer Responsibilities, and Personnel Changes

Effective 1 October 2026, the Company will reorganize its management strategy, business development and administrative functions and establish new headquarters divisions and departments. The responsibilities of 2 executive officers will be changed, and 6 general managers and others will be transferred to new positions.

Worth reading
33Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Who is moving to which position

Resolved 4 September 2026

Incoming appointee

6 items
Scheduled Appointment Date1 October 2026
Komatsu Junko (小松 順子)
Previous positionNot disclosed
New positionHead of Group Business Development Headquarters
Shibata Naoaki (柴田 直昭)
Previous positionNot disclosed
New positionGeneral Manager, Group Business Development Department, Group Business Development Headquarters
Kobayashi Hideaki (小林 秀昭)
Previous positionDeputy Head of Group Management Administration Headquarters
New positionHead of Group Management Strategy Headquarters
Tamada Kazuko (玉田 和子)
Previous positionNot disclosed
New positionHead of Group Management Strategy Office, Group Management Strategy Headquarters
Ichikawa Manabu (市川 学)
Previous positionGeneral Manager, Group Management Planning Department, Group Management Administration Headquarters
New positionGeneral Manager, Group Management Promotion Department, Group Management Strategy Headquarters
Yamada Shinya (山田 真也)
Previous positionManager, Corporate Communications Section, Group Management Planning Department, Group Management Administration Headquarters
New positionGeneral Manager, Group General Affairs Department, Group Management Administration Headquarters
Directors after the change13Number
Reason for change

To achieve “ASKA VISION 2035” and the “Medium-Term Management Plan 2028,” the first 3-year execution plan toward its realization, the Company will transfer and reorganize its management strategy, business development and administrative functions with the aim of further advancing group management.

Details of organizational changes

The Group Management Planning Department will be abolished and the Group Management Strategy Headquarters will be established. The Group Management Strategy Office and Group Management Promotion Department will be established under the new headquarters. The Group Audit Department will be reorganized as the Group Audit Office. The Group Legal Affairs and Compliance Department will be reorganized as the Group Compliance Office, with its legal affairs function separated and the Group Legal Affairs Department newly established. The Group Business Development Headquarters and its Group Business Development Department will be newly established.

Who is moving to which position
ItemDetails
Resolution date4 September 2026
Scheduled Appointment Date1 October 2026
Name of appointeeKomatsu Junko (小松 順子), Shibata Naoaki (柴田 直昭), Kobayashi Hideaki (小林 秀昭), Tamada Kazuko (玉田 和子), Ichikawa Manabu (市川 学), Yamada Shinya (山田 真也)
Appointee's new positionHead of Group Business Development Headquarters, General Manager, Group Business Development Department, Group Business Development Headquarters, Head of Group Management Strategy Headquarters, Head of Group Management Strategy Office, Group Management Strategy Headquarters, General Manager, Group Management Promotion Department, Group Management Strategy Headquarters, General Manager, Group General Affairs Department, Group Management Administration Headquarters
Appointee's previous positionNot disclosed, Not disclosed, Deputy Head of Group Management Administration Headquarters, Not disclosed, General Manager, Group Management Planning Department, Group Management Administration Headquarters, Manager, Corporate Communications Section, Group Management Planning Department, Group Management Administration Headquarters
Reason for changeTo achieve “ASKA VISION 2035” and the “Medium-Term Management Plan 2028,” the first 3-year execution plan toward its realization, the Company will transfer and reorganize its management strategy, business development and administrative functions with the aim of further advancing group management.
Number of directors after the change13 directors in total, including 5 outside directors
Details of organizational changesThe Group Management Planning Department will be abolished and the Group Management Strategy Headquarters will be established. The Group Management Strategy Office and Group Management Promotion Department will be established under the new headquarters. The Group Audit Department will be reorganized as the Group Audit Office. The Group Legal Affairs and Compliance Department will be reorganized as the Group Compliance Office, with its legal affairs function separated and the Group Legal Affairs Department newly established. The Group Business Development Headquarters and its Group Business Development Department will be newly established.
Items this document does not state (13)
Date of departureAppointee's date of birthYear the appointee joined the CompanyNumber of shares held by the appointeeName of departing officerFormer position of departing officerNew position of departing officerReason for departureWhether the incumbent will remain in officeReasons for appointmentFiling as an independent officerChange in Corporate Governance StructureSubject to Approval by the General Meeting of Shareholders

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To achieve “ASKA VISION 2035” and the “Medium-Term Management Plan 2028,” the Company will transfer and reorganize its management strategy, business development and administrative functions with the aim of further advancing group management. This will clarify the allocation of authority and responsibility, enable more agile decision-making, and strengthen the management foundation for sustainable growth.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Concerning Organizational Changes, Changes in Executive Officer Responsibilities, and Personnel Changes | ASKA Pharmaceutical Holdings Co.,Ltd. (4886) timely disclosure | Komori